About the 22nd IMS Annual Meeting

The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical, and clinical aspects. This year’s program includes:

  • Four thematic sessions on:
    • Precursor Disease
    • Risk Adaptation Management
    • Immunotherapy
    • Relapse within 1-3 lines of therapy
  • Talks and symposia on pressing topics led by the KOL of the myeloma community
  • Keynote addresses
  • Joint sessions with regulatory agencies and other organisations
  • Meet the Expert sessions
  • Oral Abstracts (on Basic Biology, Preclinical Trials, and Clinical Studies)
  • Poster presentations and discussion sessions

Land Acknowledgement

The International Myeloma Society acknowledges the land this event is held on is the traditional territory of many nations including the Mississaugas of the Credit, the Anishnabeg, the Chippewa, the Haudenosaunee and the Wendat peoples and is now home to many diverse First Nations, Inuit and Métis peoples. We also acknowledge that Toronto is covered by Treaty 13 with the Mississaugas of the Credit.




 

Title

Text